The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment.
about
Heart Failure: a Major Cardiovascular Complication of Diabetes MellitusSpotlight on valsartan-sacubitril fixed-dose combination for heart failure: the evidence to dateRole of circulating factors in cardiac aging.Cardiac Natriuretic Peptides, Hypertension and Cardiovascular RiskNatriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence.Sex Differences of the Natriuretic Peptide Polymorphism Associated With Angiographic Coronary Atherosclerosis.Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESCHemoglobin Concentration Influences N-Terminal Pro B-Type Natriuretic Peptide Levels in Hospitalized Older Adults with and without Heart Failure.Heart failure and kidney dysfunction: epidemiology, mechanisms and management.Potential beneficial effects of sacubitril-valsartan in renal disease: a new field for a new drug.Resetting the neurohormonal balance in heart failure (HF): the relevance of the natriuretic peptide (NP) system to the clinical management of patients with HFNeurohormonal activation in heart failure with reduced ejection fraction.Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy.Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides.Kallikrein-kinin system as the dominant mechanism to counteract hyperactive renin-angiotensin system.Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis.Natriuretic Peptide System Activation in Acute Heart Failure Patients with DiabetesPrevention against renal damage in rats with subtotal nephrectomy by sacubitril/valsartan (LCZ696), a dual-acting angiotensin receptor-neprilysin inhibitor.Pharmacogenomics of the Natriuretic Peptide System in Heart Failure.Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure.Pathophysiology of acute heart failure syndrome: a knowledge gap.The renal and cardiovascular effects of natriuretic peptides.Natriuretic peptides and volume handling in heart failure: the paradigm of a new treatment.LCZ696, a promising novel agent in treating hypertension (a meta-analysis of randomized controlled trials).Combined Angiotensin Receptor-Neprilysin Inhibitors Improve Cardiac and Vascular Function Via Increased NO Bioavailability in Heart Failure.
P2860
Q28066310-6B5C8ACA-EA02-4602-B283-8B50084DB378Q28070064-FB95A37B-7488-41EF-BA4F-F3A425E59D04Q30234641-5F20C551-D928-40B4-A681-58AC7D097546Q33715302-A3DD05F9-35B6-4454-94B4-50CB41507707Q33862358-0DE20329-71AD-4412-8446-91942A0AC85CQ37684980-AAD359B2-DF2B-4395-B83D-743A162557FEQ38676886-9808D7BB-513C-42A4-B7F8-FCE8C8BC26AEQ38757052-3D0108B0-0431-4FA9-8AAA-BEC7F315FAE7Q38826590-EE87056F-5154-4461-A81C-D8E22FF6DA6FQ38847918-29585C5D-19BB-4A46-90E6-737DD4725184Q38854043-01F2D19D-978A-49FC-94F6-F18F1F210375Q38973209-A34F43E8-D471-446C-A211-26B18F1512E4Q38987185-020962B0-E228-4A47-9BF5-0BEE7EB8461DQ39192295-87D45E8E-BA59-47F6-A034-5D644603E251Q39224534-8E7BD9C5-D6CA-4386-8A3C-3911E51DE587Q39641551-6E82DC7D-EDE9-4861-913F-862324E62BF9Q41448269-07FEB23D-3829-452C-8674-F55DCB8F9C5BQ46336030-1BED5AA9-6E6E-453B-AF8C-904358BC4D46Q47596916-541F9A74-7DAA-4CD7-A678-7E1C081EF690Q47855200-CF2878C2-72F8-463F-B722-5528DD167CDBQ48095229-377C5AFB-A3D6-4AE1-B476-DCB297FB6E03Q48230309-6EEF2CB4-3B32-4B10-A659-C8299C354201Q48722122-FECA24F4-0DA6-46E9-AB03-208D8B522A63Q49320299-5228C25F-975B-43FC-BCCA-A041B8A6896FQ52675558-DEED6CCB-C6E2-49D0-A5A9-194A90CE347B
P2860
The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment.
description
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
The natriuretic peptides syste ...... molecular basis to treatment.
@en
The natriuretic peptides syste ...... molecular basis to treatment.
@nl
type
label
The natriuretic peptides syste ...... molecular basis to treatment.
@en
The natriuretic peptides syste ...... molecular basis to treatment.
@nl
prefLabel
The natriuretic peptides syste ...... molecular basis to treatment.
@en
The natriuretic peptides syste ...... molecular basis to treatment.
@nl
P2860
P921
P356
P1433
P1476
The natriuretic peptides syste ...... molecular basis to treatment.
@en
P2093
Marino Carnovali
Vittoria Mastromarino
P2860
P356
10.1042/CS20150469
P407
P5008
P577
2016-01-01T00:00:00Z